Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Just In
Help Helene victims: Click to give money, give blood, donate goods or volunteer â¤ï¸ Here's your guide to help our western NC neighbors
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Mediwound Ltd Ord Sh
(NQ:
MDWD
)
16.72
+0.13 (+0.78%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
26,687
Open
16.56
Bid (Size)
16.72 (3)
Ask (Size)
16.82 (2)
Prev. Close
16.59
Today's Range
16.56 - 17.07
52wk Range
7.450 - 24.00
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
MediWound to Present at the H.C. Wainwright 26th Annual Global Investment Conference
September 03, 2024
From
MediWound Ltd.
Via
GlobeNewswire
MediWound Announces U.S. Food and Drug Administration Approval of NexoBrid® for the Treatment of Pediatric Patients with Severe Thermal Burns
August 15, 2024
Approval Helps Solidify NexoBrid’s Position in the U.S. as a Safe and Effective Non-Surgical Burn Treatment for All Ages
From
MediWound Ltd.
Via
GlobeNewswire
Performance
YTD
+48.62%
+48.62%
1 Month
-1.88%
-1.88%
3 Month
-14.69%
-14.69%
6 Month
+9.21%
+9.21%
1 Year
+67.70%
+67.70%
More News
Read More
MDWD Stock Earnings: MediWound Misses EPS, Beats Revenue for Q2 2024
August 14, 2024
Via
InvestorPlace
MediWound Reports Second Quarter 2024 Financial Results and Provides Company Update
August 14, 2024
From
MediWound Ltd.
Via
GlobeNewswire
Preview: MediWound's Earnings
March 20, 2024
Via
Benzinga
MediWound Announces Positive Results from the U.S. NexoBrid® Expanded Access Protocol (NEXT)
August 05, 2024
From
MediWound Ltd.
Via
GlobeNewswire
MediWound to Report Second Quarter 2024 Financial Results
August 02, 2024
From
MediWound Ltd.
Via
GlobeNewswire
MediWound Announces Publication of the EscharEx® Phase II ChronEx Study Results for Venous Leg Ulcers
July 29, 2024
From
MediWound Ltd.
Via
GlobeNewswire
MediWound Announces €16.25 Million Funding from the European Innovation Council Accelerator Program
July 16, 2024
From
MediWound Ltd.
Via
GlobeNewswire
MediWound Announces $25 Million Strategic Private Placement Financing
July 15, 2024
From
MediWound Ltd.
Via
GlobeNewswire
Why NIO Shares Are Trading Lower By Over 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session
July 05, 2024
Via
Benzinga
US Stocks Mixed; Jobs Figures Top Estimates For June
July 05, 2024
Via
Benzinga
Why Sharps Technology Shares Are Trading Higher By Around 32%; Here Are 20 Stocks Moving Premarket
July 05, 2024
Via
Benzinga
MDWD Stock Earnings: MediWound Beats EPS, Beats Revenue for Q1 2024
May 29, 2024
Via
InvestorPlace
MediWound Reports First Quarter 2024 Financial Results and Provides Company Update
May 29, 2024
From
MediWound Ltd.
Via
GlobeNewswire
MediWound to Report First Quarter 2024 Financial Results
May 22, 2024
From
MediWound Ltd.
Via
GlobeNewswire
MediWound to Present New Data from EscharEx® Phase II Studies at Three Leading Wound Care Conferences
April 25, 2024
From
MediWound Ltd.
Via
GlobeNewswire
MediWound Ltd. (NASDAQ: MDWD) Sets New 52-Week High in Wednesday Session
April 17, 2024
Via
Investor Brand Network
MDWD Stock Earnings: MediWound Beats EPS, Beats Revenue for Q4 2023
March 21, 2024
Via
InvestorPlace
MediWound Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update
March 21, 2024
From
MediWound Ltd.
Via
GlobeNewswire
Earnings Scheduled For March 21, 2024
March 21, 2024
Via
Benzinga
MediWound to Report Fourth Quarter and Full Year 2023 Financial Results
March 14, 2024
From
MediWound Ltd.
Via
GlobeNewswire
MediWound Announces Positive Results in Head-to-Head Comparison of EscharEx® vs. SANTYL® within the ChronEx Phase II Randomized Controlled Study
February 12, 2024
From
MediWound Ltd.
Via
GlobeNewswire
MediWound to Participate in Two Upcoming Investor Conferences
February 05, 2024
From
MediWound Ltd.
Via
GlobeNewswire
MediWound Announces that FDA has Accepted for Review the Supplement to the NexoBrid BLA to Include Pediatric Patients with Severe Thermal Burns
January 09, 2024
From
MediWound Ltd.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.